Home » BRADMER COMPLETES SUPPLY AGREEMENT WITH MDS NORDION
BRADMER COMPLETES SUPPLY AGREEMENT WITH MDS NORDION
Bradmer Pharmaceuticals Inc., a biotechnology company
dedicated to the development and commercialization of cancer therapies, has signed
a three-year contract with MDS Nordion for the formulation development and clinical
trial supply of Neuradiab in preparation for the planned multi-center clinical
trial.
CNW
Group
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May